PunjiPUNJI
Pharmaceuticals & BiotechnologySmall Cap

Novartis India Limited.

NOVARTIND · ISIN: INE234A01025

Novartis India Limited. is a small cap company in the Pharmaceuticals & Biotechnology sector, listed on the NSE under ISIN INE234A01025.

Price and day-range figures above come from the latest NSE/BSE close, not a delayed quote. Where shown, RSI (14-day), SMA50/SMA200, and ADX measure momentum and trend from real daily closing prices - an RSI above 70 or below 30 typically signals overbought or oversold conditions, and a price above its SMA200 is a common long-term uptrend marker. ADTV (20-day average daily traded value) reflects real liquidity, not a projection. Fundamentals, when available, come from the company's own filed financials rather than a third-party estimate.

Close (as of 2026-10-29)
₹1812.8
-0.47% today
Day Range
₹1779.8 - ₹1834
Market Cap (Small Cap)
₹4,475.947 Cr
Quality Score (as of 2026-06-30)
75/100

Price History

CHART

Novartis India Limited. - growth of ₹100

Growth of ₹100 invested on 2021-11-30, not raw price - the standard way to compare performance regardless of price level. Daily resolution for the last 90 days, weekly up to 2 years, monthly beyond that.

-31621552483412021-11-302023-12-052025-02-072025-07-252026-01-162026-07-032026-08-282026-10-052026-10-29

1M

-5.53%

3M

+17.94%

6M

+75.91%

1Y

+109.96%

3Y CAGR

+39.19%

5Y CAGR

-

Earnings (TTM)

LEARN: Revenue and PAT · EPS · P/E

CHART

Novartis India Limited. - revenue & profit (TTM)

Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.

0 Cr104 Cr208 Cr312 Cr416 CrQ3 FY2026Q4 FY2026Q1 FY2027
Revenue (TTM)PAT (TTM)

-

EBITDA Margin (TTM)

Technicals

1846.31

SMA (50)

1335.75

SMA (200)

110.29%

1Y Return

7.778

Avg Traded Value (20D, ₹Cr)

As of 2026-10-29.

Shareholding Pattern

CHART

Shareholding by category

As of 2026-06-30.

70.68%29.32%TOP 3100%
Promoter 70.68%Public 29.32%NonPromoterNonPublic 0%

Corporate Actions

No corporate actions on record for this stock.

Recent Deals

No recent block/bulk/short-sell deals on record for this stock.

Frequently asked questions

What is Novartis India Limited.'s 1-year and 3-year return?

Novartis India Limited.'s 1-year price return is +109.96%. Its 3-year CAGR (annualized return) is +39.19%. Both are price-only returns (no dividends added back), computed from the nearest available trading day to each anniversary - not a forecast of future performance.

What is Novartis India Limited.'s latest financial performance?

Novartis India Limited.'s trailing-twelve-month (TTM) revenue as of 2026-06-30 is ₹371 Cr, with a TTM profit after tax of ₹98 Cr and an EBITDA margin of null%. TTM figures sum the most recent four reported quarters rather than a single quarter, which smooths out seasonal swings in a business's revenue and profit. EPS (earnings per share) over this TTM window is ₹39.61.

What is Novartis India Limited.'s quality score?

Novartis India Limited. has a Punji quality score of 75 out of 100 as of 2026-06-30. This composite score is computed from the company's reported fundamentals (profitability, balance-sheet strength, and consistency of earnings, among other factors) and is designed to be comparable across companies in different sectors. A higher score indicates a fundamentally stronger business by these measures, though it isn't a price target or a buy/sell signal - a high-quality company can still be expensively priced, and a lower-scoring one can still be a reasonable investment at the right valuation.

What do Novartis India Limited.'s technical indicators show?

As of 2026-10-29, Novartis India Limited.'s RSI (14-day) is 45.11 - readings above 70 typically signal an overbought stock, below 30 an oversold one, so this reading sits in neutral territory. Its 50-day moving average is currently above its 200-day moving average, a "golden cross" setup when the shorter average is above (often read as a bullish medium-term signal) or a "death cross" when below (often read as bearish). These are backward-looking statistical measures, not predictions of future price movement.

Who are the major shareholders of Novartis India Limited.?

As of 2026-06-30, Novartis India Limited.'s shareholding is split across Promoter (70.68%), Public (29.32%), NonPromoterNonPublic (0%). Promoter holding of 70.68% indicates the founders/controlling group's own stake in the company - a higher promoter holding is often read as a sign of management's confidence in the business, though it should be considered alongside pledge status and recent buying/selling activity, which this figure alone doesn't capture.

Stock data · Not financial advice · Past performance does not indicate future returns